Bottle Label 600 mg (71610 0777 30)
Gabapentin Tablet
Product Images NDC 71610-777
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 (Image 01)
Figure 2 (Image 02)
This is a description of a study evaluating the effects of different doses of Gabapentin in reducing pain. The study lasted for 7 weeks, with a baseline pain score measured at the beginning. The participants were divided into three groups: one receiving a placebo, one receiving a daily dose of 1800 mg of Gabapentin, and one receiving a daily dose of 2400 mg of Gabapentin. The mean pain scores were recorded throughout the weeks, showing the potential effectiveness of Gabapentin in reducing pain.*
Figure 3 (Image 03)
Image-04 (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
